journal article·2013-07

Gelatin coating to stabilize the transfection ability of nucleic acid polyplexes

Laura Rose, Hamidreza Montazeri Aliabadi, Hasan Uludağ

Acta Biomaterialia· Volume 9· Issue 7
Publisher page

Abstract

Amphiphilic polymers are effective in complexing and delivering therapeutic nucleic acids, such as plasmid DNA (pDNA) and short interfering RNA (siRNA). However, long-term stability of the complexes is not desirable, as it may have an impact on the transfection efficiency in vivo. To develop a method to preserve complex stability we first showed that pDNA complexes formed with the amphiphilic polymer linoleic acid-substituted polyethylenimine (PEI-LA) and incubated at 37°C lost ~90% of their transfection efficiency after only 24h of complex formation. Polyethyleneglycol modification of complexes to control the increase in complex size and incubation in scaffolds used for implantation did not preserve the transfection ability of the complexes. Among a variety of approaches explored, gelatin coating of complexes was found to be the best at maintaining the original transfection efficiency. Mechanistic studies suggested that improved complex uptake, not size stability, was responsible for retention of the transfection efficiency. Similarly to the results with pDNA, gelatin coating also prevented the decreases in uptake and silencing efficiency of siRNA complexes observed following incubation at 37°C. Gelatin-stabilized complexes were, furthermore, effective in vivo and led to subcutaneous transgene expression with a low pDNA dose that was otherwise ineffective. We conclude that a simple gelatin coating approach offers an efficient means to preserve the transfection efficiency of polyplexes.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (34)

Show source-provided references
1. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration10.1038/10473 ↗
2. In vivo evaluation of plasmid DNA encoding OP-1 protein for spine fusion10.1097/01.brs.0000232721.59901.45 ↗
3. In vitro and in vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stents10.1002/jbm.a.32488 ↗
4. Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells10.1038/leu.2009.101 ↗
5. Long term stability of poly((2-dimethylamino)ethyl methacrylate)-based gene delivery systems10.1023/A:1018907310472 ↗
6. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy10.1016/j.ejpb.2008.09.015 ↗
7. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes10.1073/pnas.93.12.5753 ↗
8. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery10.1016/j.ejpb.2008.03.014 ↗
9. Lipid and hydrophobic modification of cationic carriers on route to superior gene vectors10.1039/b916362j ↗
10. Simple and effective osteoinductive gene therapy by local injection of a bone morphogenetic protein-2-expressing recombinant adenoviral vector and FK506 in rats10.1038/sj.gt.3302176 ↗
11. Characterization of the distinct orthotopic bone forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery10.1038/sj.gt.3302298 ↗
12. Efficacy and cytotoxicity of cationic-agent-mediated nonviral gene transfer into osteoblasts10.1002/jbm.a.30160 ↗
13. Occurrence of leukaemia following gene therapy of X-linked SCID10.1038/nrc1122 ↗
14. Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin microspheres10.1021/mp200155t ↗
15. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in rat10.1038/sj.gt.3302075 ↗
16. Stability of poly(ethylene glycol)-graft-polyethylenimine copolymer/DNA complexes: influences of PEG molecular weight and PEGylation degree10.1007/s10856-009-3903-1 ↗
17. PEGylation of poly(ethylene imine) affects stability of complex with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice10.1021/bc049743q ↗
18. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells10.1016/j.jconrel.2009.03.010 ↗
19. Aliphatic lipid substitution on 2kDa polyethylenimine improves plasmid delivery and transgene expression10.1021/mp900074d ↗
20. Small-interfering RNA-eluting surfaces as a novel concept for intravascular local gene silencing10.2119/molmed.2011.00143 ↗
21. HSP47 siRNA conjuageted with cationized gelatin microspheres suppresses peritoneal fibrosis in mice10.1016/j.actbio.2012.03.050 ↗
22. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression10.1006/bbrc.1999.1975 ↗
23. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery10.1016/j.ejphar.2011.09.023 ↗
24. Chitosan-graft-(PEI–beta-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery10.1016/j.biomaterials.2011.07.038 ↗
25. Analysis of cationic liposome-mediated interactions of plasmid DNA with murine and human melanoma cells in vitro10.1074/jbc.272.31.19480 ↗
26. Protection of oligonucleotides against enzymatic degradation by PEGylated and nonPEGylated branched polyethyleneimine10.1021/bm0611578 ↗
27. Amphiphilic, low molecular weight poly(ethylene imine) derivatives with enhanced stability for efficient pulmonary gene delivery10.1002/jgm.1538 ↗
28. Protein expression following non-viral delivery of plasmid DNA coding for basic FGF and BMP-2 in a rat ectopic model10.1016/j.biomaterials.2012.01.031 ↗
29. Mechanistic studies on aggregation of polyethylenimine–DNA complexes and its prevention10.1002/bit.20444 ↗
30. Osteoinduction by bone morphogenetic protein 2-expressing adenoviral vector: application of biomaterial to mask the host immune response10.1089/1043034041361208 ↗
31. Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis10.1161/ATVBAHA.109.186429 ↗
32. Infuence of the polyanion on the physic-chemical properties and biological activities of polyanion/DNA/polycation tertiary polyplexes10.1016/j.actbio.2012.04.034 ↗
33. Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons10.1016/j.neuron.2007.01.033 ↗
34. Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery10.1016/j.biomaterials.2009.10.011 ↗